$2.18
9.92% today
Nasdaq, Apr 04, 10:04 pm CET
ISIN
US0044682039
Symbol
ACHV
Sector
Industry

Achieve Life Sciences, Inc. Stock price

$2.18
-0.73 25.09% 1M
-2.84 56.57% 6M
-1.34 38.07% YTD
-2.30 51.34% 1Y
-5.52 71.69% 3Y
-4.42 66.97% 5Y
-4,727.82 99.95% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-0.24 9.92%
ISIN
US0044682039
Symbol
ACHV
Sector
Industry

Key metrics

Market capitalization $83.94m
Enterprise Value $59.54m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 4.02
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-39.07m
Free Cash Flow (TTM) Free Cash Flow $-29.77m
Cash position $34.36m
EPS (TTM) EPS $-1.23
P/E forward negative
Short interest 11.36%
Show more

Is Achieve Life Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Achieve Life Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Achieve Life Sciences, Inc. forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Achieve Life Sciences, Inc. forecast:

Buy
100%

Financial data from Achieve Life Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 0.23 0.23
28% 28%
-
-0.23 -0.23
28% 28%
-
- Selling and Administrative Expenses 16 16
46% 46%
-
- Research and Development Expense 23 23
44% 44%
-
-39 -39
44% 44%
-
- Depreciation and Amortization 0.23 0.23
28% 28%
-
EBIT (Operating Income) EBIT -39 -39
43% 43%
-
Net Profit -40 -40
34% 34%
-

In millions USD.

Don't miss a Thing! We will send you all news about Achieve Life Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Achieve Life Sciences, Inc. Stock News

Neutral
Seeking Alpha
24 days ago
Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ET Company Participants Nicole Jones - IR Richard Stewart - Chief Executive Officer Cindy Jacobs - President and Chief Medical Officer Jaime Xinos - Chief Commercial Officer Mark Oki - Chief Financial Officer Conference Call Participants Gary Nachman - Raymond James Thomas Flaten - Lake Street Cap...
Neutral
GlobeNewsWire
24 days ago
Reiterates Planned Cytisinicline NDA Submission Expected at the End of Q2 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, March 11, 2025 SEATTLE and VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline a...
Neutral
GlobeNewsWire
28 days ago
SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that the company will be presenting at the Barclays 27th Annual Global Healthcare...
More Achieve Life Sciences, Inc. News

Company Profile

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Head office United States
CEO Richard Stewart
Employees 25
Founded 1991
Website www.achievelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today